Scott Gottlieb Quizzed On Big Pharma Ties In FDA Confirmation Hearing
Scott Gottlieb
President Trump’s nominee to lead the U.S. Food and Drug Administration, Dr. Scott Gottlieb, was questioned about his ties to the pharmaceutical industry by Democrats on a key Senate committee on Wednesday ahead of a vote on whether to advance his nomination for a vote by the full Senate.
Gottlieb, 44, is a former FDA deputy commissioner who has advocated a loosening of requirements needed for approval of new medical products. He is also a resident fellow at the conservative American Enterprise Institute think tank, a partner at a large venture capital fund and sits on the boards of multiple healthcare companies.
Democrats on the Senate Committee on Health, Education, Labor and Pensions, questioned whether Gottlieb’s ties to the pharmaceutical industry would compromise his ability to act impartially.
Senator Chris Murphy of Connecticut said Democrats had “a level of discomfort” with Gottlieb’s nomination, not just due to his private industry background but because of his prior activity as a political advisor to Republican presidential candidates and opposition to the Affordable Care Act.
Overall, the hearing went smoothly for Gottlieb and covered his views on clinical trials, e-cigarettes, the lipoid epidemic and vaccines.
The Forward is free to read, but it isn’t free to produce
I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward.
Now more than ever, American Jews need independent news they can trust, with reporting driven by truth, not ideology. We serve you, not any ideological agenda.
At a time when other newsrooms are closing or cutting back, the Forward has removed its paywall and invested additional resources to report on the ground from Israel and around the U.S. on the impact of the war, rising antisemitism and polarized discourse.
This is a great time to support independent Jewish journalism you rely on. Make a gift today!
— Rachel Fishman Feddersen, Publisher and CEO
Support our mission to tell the Jewish story fully and fairly.
Dive In
-
Fast Forward Despite ceasefire, residents of northern Israel are wary of return, fearing another Oct. 7
-
Fast Forward ‘September 5’ focuses on news, not Jews, in dramatizing 1972 Munich attack on Israeli Olympians
-
Fast Forward An Israeli cafe chain launched by and for Oct. 7 survivors is expanding to more cities
-
Fast Forward What happened to relics of Syria’s Jewish history? Assad’s collapse spurs efforts to assess the damage.
Most Popular
- 1
Fast Forward Why the Antisemitism Awareness Act now has a religious liberty clause to protect ‘Jews killed Jesus’ statements
- 2
News School Israel trip turns ‘terrifying’ for LA students attacked by Israeli teens
- 3
Culture Cardinals are Catholic, not Jewish — so why do they all wear yarmulkes?
- 4
Music After decades of waiting, we’re finally getting a Bob Dylan-Barbra Streisand duet
In Case You Missed It
-
Fast Forward A Jewish nonprofit may have accidentally caused Michigan to drop charges against pro-Palestinian activists
-
Culture For Christian nationalists, Trump’s pope picture isn’t a joke
-
Opinion Is Israel really going to reoccupy Gaza? Ask Trump
-
Yiddish World A photo of my bubbe when Jewish stores still had Yiddish signs
-
Shop the Forward Store
100% of profits support our journalism
Republish This Story
Please read before republishing
We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines.
You must comply with the following:
- Credit the Forward
- Retain our pixel
- Preserve our canonical link in Google search
- Add a noindex tag in Google search
See our full guidelines for more information, and this guide for detail about canonical URLs.
To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at [email protected], subject line “republish,” with any questions or to let us know what stories you’re picking up.